# CAN-DOSE Study: Cessation With Augmented Nicotine for Dual Use Of Smoking and E-cigarettes

> **NCT06087328** · PHASE2 · COMPLETED · sponsor: **Medical University of South Carolina** · enrollment: 46 (actual)

## Conditions studied

- Smoking Cessation
- Electronic Cigarette Use
- Cigarette Smoking

## Interventions

- **DRUG:** Regular Nicotine patch and lozenge dose
- **DRUG:** Augmented Nicotine patch and lozenge dose

## Key facts

- **NCT ID:** NCT06087328
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-05
- **Primary completion:** 2024-11-05
- **Final completion:** 2024-11-05
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2025-11-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06087328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06087328, "CAN-DOSE Study: Cessation With Augmented Nicotine for Dual Use Of Smoking and E-cigarettes". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT06087328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*